Metabolic profile provides prognostic value better than galectin-3 in patients with heart failure

Citations of this article
Mendeley users who have this article in their library.


Background Metabolic profiles have been shown to provide prognostic information in patients with heart failure (HF). Galectin-3 (Gal-3), indicating cardiac fibrosis, is a documented biomarker of prognosis in HF. It is unknown whether metabolic profiles provide prognostic value better than Gal-3. Methods and results This study analyzed 212 hospitalized HF patients, measuring metabolic score (composed by butyrylcarnitine, dimethylarginine/arginine ratio, spermidine, and total essential amino acids) and Gal-3. Endpoints were composite events (death/HF-related re-hospitalization). The median of metabolic scores and Gal-3 levels were 3.1 (1.3–5.2) and 17.8 ng/mL (4.7–100 ng/mL), respectively. Patients with higher metabolic scores had worse functional classes, higher atrial fibrillation incidences, levels of Gal-3 and B-type natriuretic peptide (BNP), but lower albumin levels and glomerular filtration rate. Correlations of metabolic score to Gal-3 and BNP were significant, but weak (r = 0.34 and 0.41, respectively, both p < 0.001). During a follow-up period of 4.2 ± 1.4 years, there were 91 (42.9%) composite events. In univariate analysis, significant predictors of composite events were age, functional class, atrial fibrillation, levels of hemoglobin, log (Gal-3), log (BNP) and metabolic score. In multivariable analysis, adjusted for above variables, metabolic score remained a strong predictor of combined endpoints (hazard ratio = 2.596, 95% confidence interval = 1.649–4.087, p < 0.001). C-statistics for the prediction of composite events significantly increased when metabolic score was incorporated into the model with established risk factors, BNP and Gal-3 [0.76 (0.70–0.83) vs. 0.66 (0.58–0.74), p = 0.032]. Conclusions Metabolic profile provides prognostic value for HF patients better than Gal-3.




Wang, C. H., Cheng, M. L., Liu, M. H., Kuo, L. T., & Shiao, M. S. (2017). Metabolic profile provides prognostic value better than galectin-3 in patients with heart failure. Journal of Cardiology, 70(1), 92–98.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free